Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 121 ~ 140 of 25713, Page 7 of 1287
121. WHO and EU commit to work together to accelerate progress on health
Dr Tedros Adhanom Ghebreyesus, Director-General of WHO has completed a series of meetings with President Juncker and senior European Commission officials. He also signed a joint statement with the European Parliament.
11/21/2018 WHO
122. FDA Proposes Regulations as Teen E-Cigarette Use Skyrockets 78% in 1 Year
Use of e-cigarettes (also known as vaping) by high school students has jumped 78% since last year, according to the US Centers for Disease Control and Prevention (CDC).
11/21/2018 American Cancer Society (ACS)
123. Researchers Use MRI to Predict Alzheimer’s Disease
MRI assessment of the brain’s white matter using diffusion tensor imaging (DTI) is a promising option for analysis of dementia risk.
11/20/2018 Radiological Society of North America (RSNA)
124. FDA approves first treatment specifically for patients with rare and life-threatening type of immune disease
The U.S. Food and Drug Administration today approved Gamifant (emapalumab-lzsg) for the treatment of pediatric (newborn and above) and adult patients with primary hemophagocytic lymphohistiocytosis (HLH)...
11/20/2018 U.S. FOOD & DRUG ADMINISTRATION
125. Abbott Initiates Study to Evaluate Ablation as a Frontline Treatment for Patient''s Suffering from a Common but Complex Cardiac Arrhythmia
LESS-VT Study is the first U.S. clinical trial to evaluate the safety and effectiveness of ablation treatment for patients with monomorphic ventricular tachycardia, a common heart rhythm disorder
11/20/2018 Abbott
126. Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on FDA’s updates to Medical Device Safety Action Plan to enhance post-market safety
11/20/2018 U.S. FOOD & DRUG ADMINISTRATION
127. FDA warns marketers of products labeled as dietary supplements that contain tianeptine for making unproven claims to treat serious conditions, including opioid use disorder
11/20/2018 U.S. FOOD & DRUG ADMINISTRATION
128. Medtronic Reports Second Quarter Financial Results
Revenue of $7.5 Billion Increased 6.1% Reported; Increased 7.5% Organic / GAAP Diluted EPS of $0.82; Non-GAAP Diluted EPS of $1.22 / Cash Flow from Operations of $2.9 Billion in First Six Months vs. $1.6 Billion in Prior Year; Free Cash Flow of $2.4 Billion in First Six Months vs. $1.1 Billion in Prior Year / Company Increases FY19 Organic Revenue Growth Guidance
11/20/2018 Medtronic
129. WHO and partners launch new country-led response to put stalled malaria control efforts back on track
11/19/2018 World Health Organization (WHO)
130. Statement from FDA Commissioner Scott Gottlieb, M.D., on a new qualified health claim for consuming oils with high levels of oleic acid to reduce coronary heart disease risk
11/19/2018 U.S. FOOD & DRUG ADMINISTRATION
131. CDC Establishes AFM Task Force
CDC Director Robert R. Redfield, M.D., announced today the establishment of an Acute Flaccid Myelitis (AFM) Task Force (Task Force) to aid in the ongoing investigation to define the cause of, and improve treatment and outcomes for, patients with AFM.
11/19/2018 Centers for Disease Control and Prevention
132. How to Test Your Home for Radon
Getting your home tested for radon can help protect you and your family from a key cause of lung cancer.
11/19/2018 American Cancer Society
133. Is My Child Overweight?
About 1 out of every 3 children in the US is overweight or obese, something many parents often do not realize. Learn how to recognize unhealthy weight in your child and what to do about it.
11/19/2018 American Cancer Society
134. Shoulder “Brightness” on Ultrasound May Be a Sign of Diabetes
Brightness of the shoulder’s deltoid muscle on ultrasound may be an indicator of diabetes or pre-diabetes.
11/19/2018 Radiological Society of North America
135. Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugs
11/16/2018 U.S. FOOD & DRUG ADMINISTRATION
136. Statement from USDA Secretary Perdue and FDA Commissioner Gottlieb on the regulation of cell-cultured food products from cell lines of livestock and poultry
11/16/2018 U.S. FOOD & DRUG ADMINISTRATION
137. FDA approves new drug to treat travelers’ diarrhea
The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood ...
11/16/2018 U.S. FOOD & DRUG ADMINISTRATION
138. Patients with shoulder arthritis have new options to avoid risks of total shoulder replacement
A new review article published in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) finds arthroscopic (joint replacement or reconstruction) management could be a promising option for young, active patients diagnosed with GHOA.
11/16/2018 American Academy of Orthopaedic Surgeons
139. FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot
The U.S. Food and Drug Administration today expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma (PTCL). This is the first FDA approval for treatment of newly diagnosed PTCL, and the agency used a new review program to complete the approval more ....
11/16/2018 U.S. FOOD & DRUG ADMINISTRATION
140. New Findings Presented at the VEITHsymposium Reiterate Consistent, Durable Outcomes in Complex Aortic Disease with Heli-FX(TM) Endoanchor(TM) System
Three-Year Data from the ANCHOR Registry Reiterate Applicability in Patients with Hostile Aortic Neck Anatomies
11/16/2018 Medtronic
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱